Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.57% today. In the last week its performance is 2.13%, and 6.96% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70.17, so today’s gain of 0.57% is a significant step towards its target price. The GAP today is therefore 0.08%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 104469.73, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 70.50%.
At the current price of 66.48, it has a dividend yield of 3.45%, and its target price is 70.17. This is with a profit margin of *TBA, and total debt/equity of *TBA. AbbVie Inc. (NYSE:ABBV) has a P/E of 19.8, as well as a forward P/E of 11.78.
With a current EPS of 3.34, and a forecasted EPS growth for next year at 18.10%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.03%.
Performance for the year is -2.34%. Since its IPO date on 1/2/2013, the total performance to date is 14.83%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 2535021, while its average volume is 8924.57. Whilst the total gain today was 0.57%, it did have a day high of -0.89%.
Volatility for this week has been at 1.45%, and 1.44% for the month. The 52-week low for AbbVie Inc., ABBV has been 50.54%, while the 52-week-high has reached -2.44%.
Looking at its return of investments, which is 16.90%, and its return on assets is *TBA. AbbVie Inc. (NYSE:ABBV) has an operating margin of 36.40%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.24, and the P/S is 4.39, along with a P/B of 23.02. Meanwhile it has a p/cash of *TBA.